首页 | 本学科首页   官方微博 | 高级检索  
     


Triple therapy with boceprevir or telaprevir in a European cohort of cirrhotic HIV/HCV genotype 1‐coinfected patients
Authors:Patrick Miailhes  Camille Gilbert  Karine Lacombe  Joop E. Arends  Massimo Puoti  Jürgen K. Rockstroh  Philippe Sogni  Hélène Fontaine  Eric Rosenthal  Maria Winnock  Marc‐Arthur Loko  Linda Wittkop  François Dabis  Dominique Salmon  the ESCMID European Study Group on Viral Hepatitis
Affiliation:1. Department of Infectious and Tropical Diseases, Croix Rousse Hospital, Hospices Civils de Lyon, Lyon, France;2. Centre INSERM U897‐Epidemiologie‐Biostatistique, INSERM, ISPED, Bordeaux, France;3. Sorbonne Universités, UPMC Univ Paris 06, UMR_S 1136, Institut Pierre Louis d'Epidémiologie et de Santé Publique, Paris, France;4. Department of Infectious and Tropical Diseases, Saint‐Antoine Hospital, AP‐HP, Paris, France;5. Department of Internal Medicine and Infectious Diseases, University Medical Center Utrecht (UMCU), Utrecht, the Netherlands;6. Infectious Diseases Department, AO Niguarda Ca' Granda, Milano, Italy;7. Infectious Diseases Department, University of Bonn, Bonn, Germany;8. Hepatology Unit, Cochin Hospital, AP‐HP, Paris, France;9. Paris and Cochin Institute, INSERM‐U1016, Paris‐Descartes University, Paris, France;10. Department of Internal Medicine, CHU de Nice, Archet Hospital, University of Nice Sophia Antipolis, Nice, France;11. CHU de Bordeaux, P?le de Santé Publique, Service d'Information Médicale, Bordeaux, France;12. Department of Internal Medicine and Infectious Diseases, Cochin Hospital, Paris Descartes University, AP‐HP, Paris, France
Abstract:
Keywords:boceprevir  cirrhosis  HIV/HCV genotype 1 coinfection  telaprevir
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号